接受调整剂量5-氮杂胞苷治疗的骨髓增生异常综合征和慢性粒单核细胞白血病患者的皮肤白血病 - Suppr

Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.

作者信息

Infante María Stefania, Muñoz Carolina, Heras Cecilia, Foncillas María Angeles, González Isabel, Lucea Irene, Echavarria Eva, Aramendi Teresa, Hernández José Angel

机构信息

Department of Hematology.

Department of Dermatology.

出版信息

Eur J Dermatol. 2015 Nov-Dec;25(6):622-3. doi: 10.1684/ejd.2015.2661.

DOI:10.1684/ejd.2015.2661

PMID:26552844

Abstract

摘要

相似文献

Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.

Eur J Dermatol. 2015 Nov-Dec;25(6):622-3. doi: 10.1684/ejd.2015.2661.

Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.

Acta Clin Belg. 2015 Feb;70(1):34-43. doi: 10.1179/2295333714Y.0000000102. Epub 2014 Dec 2.

Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia.

Curr Med Res Opin. 2015 Jan;31(1):35-42. doi: 10.1185/03007995.2014.972499. Epub 2014 Oct 17.

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.

J Clin Oncol. 2011 Jun 20;29(18):2521-7. doi: 10.1200/JCO.2010.34.4226. Epub 2011 May 16.

Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.

Leuk Res. 2015 May;39(5):501-4. doi: 10.1016/j.leukres.2015.02.004. Epub 2015 Feb 16.

Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.

Acta Haematol. 2015;133(1):64-6. doi: 10.1159/000363643. Epub 2014 Aug 14.

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).

Eur J Haematol. 2018 Dec;101(6):766-773. doi: 10.1111/ejh.13160. Epub 2018 Oct 25.

Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone.

Leuk Res. 2012 Sep;36(9):e211-3. doi: 10.1016/j.leukres.2012.04.029. Epub 2012 May 22.

Azacitidine-associated Sweet's syndrome.

Am J Health Syst Pharm. 2012 May 15;69(10):869-71. doi: 10.2146/ajhp110523.

Azacitidine-induced Sweet syndrome: Two unusual clinical presentations.

Australas J Dermatol. 2018 Aug;59(3):e224-e225. doi: 10.1111/ajd.12727. Epub 2017 Oct 18.

引用本文的文献

Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.

Case Rep Hematol. 2021 Apr 21;2021:6640597. doi: 10.1155/2021/6640597. eCollection 2021.

A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy.

Turk J Haematol. 2017 Jun 5;34(2):192-193. doi: 10.4274/tjh.2016.0220. Epub 2017 Feb 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.

作者信息

机构信息

出版信息

相似文献

引用本文的文献